Literature DB >> 3053551

Cefuroxime axetil.

A M Emmerson1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3053551     DOI: 10.1093/jac/22.2.101

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  7 in total

1.  beta-Lactamase stability and in vitro activity of oral cephalosporins against strains possessing well-characterized mechanisms of resistance.

Authors:  C C Sanders
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

2.  Pharmacodynamic model for β-lactam regimens used in surgical prophylaxis: model-based evaluation of standard dosing regimens.

Authors:  XiangQing Song; MingHui Long
Journal:  Int J Clin Pharm       Date:  2018-08-16

Review 3.  Cefetamet pivoxil clinical pharmacokinetics.

Authors:  R A Blouin; K Stoeckel
Journal:  Clin Pharmacokinet       Date:  1993-09       Impact factor: 6.447

4.  Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis.

Authors:  D Henry; G E Ruoff; J Rhudy; A Puopolo; M Drehobl; J Schoenberger; G Giguere; J J Collins
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

Review 5.  Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  C M Perry; R N Brogden
Journal:  Drugs       Date:  1996-07       Impact factor: 9.546

6.  Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans.

Authors:  S W Luger; P Paparone; G P Wormser; R B Nadelman; E Grunwaldt; G Gomez; M Wisniewski; J J Collins
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

7.  Formulation and characterization of Cefuroxime Axetil nanoemulsion for improved bioavailability.

Authors:  Yomesh Patel; Aditi Poddar; Krutika Sawant
Journal:  J Pharm Bioallied Sci       Date:  2012-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.